Evidence map›Paper›PMID 29018182›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Role of Nitric Oxide Pathway in Development and Progression of Chronic Kidney Disease in Rats Sensitive and Resistant to its Occurrence in an Experimental Model of 5/6 Nephrectomy.

Marek Saracyn, Katarzyna Czarzasta, Marek Brytan, Piotr Murawski, Sławomir Lewicki, Tomasz Ząbkowski, Robert Zdanowski, Agnieszka Cudnoch-Jędrzejewska, Grzegorz Wiktor Kamiński, Zofia Wańkowicz

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Marek SaracynDepartment of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland.
Katarzyna CzarzastaDepartment of Experimental and Clinical Physiology, Laboratory Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Marek BrytanDepartment of Pharmacology and Toxicology, Military Institute of Hygiene and Epidemiology, Warsaw, Poland.
Piotr MurawskiDepartment of Information Technology, Military Institute of Medicine, Warsaw, Poland.
Sławomir LewickiDepartment of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland.
Tomasz ZąbkowskiDepartment of Urology, Military Institute of Medicine, Warsaw, Poland.
Robert ZdanowskiDepartment of Regenerative Medicine, Military Institute of Hygiene and Epidemiology, Warsaw, Poland.
Agnieszka Cudnoch-JędrzejewskaDepartment of Internal Diseases, Nephrology, and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Grzegorz Wiktor KamińskiDepartment of Endocrinology and Isotope Therapy, Military Institute of Medicine, Warsaw, Poland.
Zofia WańkowiczDepartment of Internal Diseases, Nephrology, and Dialysis, Military Institute of Medicine, Warsaw, Poland.
Wojskowy Instytut Medycyny Lotniczej · PLWojskowy Instytut Higieny i Epidemiologii · PLMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Understanding the mechanisms conditioning development of chronic kidney disease (CKD) is still a challenge. The aim of this study was to evaluate the activity of the intrarenal nitric oxide (NO) pathway in the context of sensitivity or resistance of different animal strains to the development and degree of renal failure. MATERIAL AND METHODS Two rat strains were used: Wistar (WR) and Sprague-Dawley rats (SDR) in a model of CKD - 5/6 nephrectomy. We assessed parameters of renal failure and expression of nitric oxide synthase (NOS) isoforms in renal cortex and medulla. RESULTS We did not observe renal failure in WR, and CKD developed in SDR with increase of creatinine and urea concentration as well as decrease of diuresis and glomerular filtration. In the renal cortex, baseline expression of NOS2 was higher in WR than in SDR. 5/6 nephrectomy resulted in reduction of NOS2 in both strains and NOS3 in WR. In the renal medulla, baseline NOS2 expression was higher in SDR, and nephrectomy resulted in its decrease only in SDR. Although baseline NOS3 expression was higher in SDR, the NOS3 expression after nephrectomy was higher in WR rats. CONCLUSIONS In model of CKD - 5/6 nephrectomy, SDR proved to be sensitive and WR resistant to development of CKD. The intrarenal activity of the nitric oxide pathway was the factor that differentiated both strains. This mechanism may be responsible for insensitivity of WR to development of renal failure in this model of CKD.

Indexed as

AnimalsCreatinineDisease Models, AnimalDisease ProgressionKidneyKidney Failure, ChronicMaleModels, TheoreticalNephrectomyNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INitric Oxide Synthase Type IIIProtein IsoformsRatsRats, Sprague-DawleyCreatinineNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type INitric Oxide Synthase Type IIIProtein Isoforms

Identifiers

PMID29018182
PMCPMC5649515
OpenAlexW2761612426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.